Legal & General Group
AUTL

Legal & General Group’s Autolus Therapeutics AUTL Stock Holding History

Legal & General Group’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-299,836
Closed -$463K – 3429
2025
Q1 		$463K Buy
299,836
+2,100
+0.7% +$4.26K ﹤0.01% 2420
2024
Q4 		$697K Buy
297,736
+237,224
+392% +$802K ﹤0.01% 2349
2024
Q3 		$219K Hold
60,512
– – ﹤0.01% 2666
2024
Q2 		$211K Buy
+60,512
New +$261K ﹤0.01% 2659
2022
Q4 		– Sell
-67,517
Closed -$146K – 3419
2022
Q3 		$146K Hold
67,517
– – ﹤0.01% 2717
2022
Q2 		$192K Buy
67,517
+34,813
+106% +$106K ﹤0.01% 2651
2022
Q1 		$137K Hold
32,704
– – ﹤0.01% 2791
2021
Q4 		$170K Buy
32,704
+3,720
+13% +$22.3K ﹤0.01% 2774
2021
Q3 		$190K Buy
28,984
+7,647
+36% +$48.3K ﹤0.01% 2709
2021
Q2 		$142K Buy
21,337
+10,446
+96% +$64.8K ﹤0.01% 2623
2021
Q1 		$63K Hold
10,891
– – ﹤0.01% 2749
2020
Q4 		$97K Buy
10,891
+2,231
+26% +$23.8K ﹤0.01% 2594
2020
Q3 		$100K Hold
8,660
– – ﹤0.01% 2491
2020
Q2 		$138K Buy
8,660
+4,037
+87% +$44.8K ﹤0.01% 2446
2020
Q1 		$27K Buy
4,623
+1,108
+32% +$10.2K ﹤0.01% 2794
2019
Q4 		$46K Buy
3,515
+3,369
+2,308% +$44.1K ﹤0.01% 2839
2019
Q3 		$2K Hold
146
– – ﹤0.01% 3342
2019
Q2 		$2K Buy
146
+100
+217% +$2.24K ﹤0.01% 3477
2019
Q1 		$1K Hold
46
– – ﹤0.01% 3341
2018
Q4 		$1K Buy
+46
New +$1.51K ﹤0.01% 3375

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Legal & General Group's AUTL Position: Q2 2025 in Review

Legal & General Group sold out of Autolus Therapeutics (AUTL) in Q2 2025, closing a stake of 299,836 shares — an estimated $463K sold.

Legal & General Group first reported a position in AUTL in Q4 2018 and held it in 20 quarters. The position peaked at $697K in Q4 2024. 94 funds tracked by Wall St. Rank hold AUTL as of Q2 2025.

  • Legal & General Group reported no remaining Autolus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 299,836 Autolus Therapeutics shares in Q2 2025, an estimated $463K.
  • Legal & General Group first reported a position in Autolus Therapeutics in Q4 2018 and held it in 20 quarters.
  • Legal & General Group's Autolus Therapeutics position peaked at $697K in Q4 2024.
  • 94 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.